|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating (loss)/profit | |||
| Depreciation and amortization of property, plant and equipment and intangible assets | |||
| Depreciation of right-of-use assets | |||
| Gain on disposal of intangible assets | |||
| Share-based payments expense for the year | |||
| Impact from foreign exchange movements | |||
| Settlement of tax on employee awards | |||
| Increase in trade receivables | |||
| (Increase)/decrease in other assets | |||
| Increase in inventories | |||
| Increase/(decrease) in trade and other payables | |||
| Increase/(decrease) in provisions and other liabilities | |||
| Cash (used in)/provided by operations | |||
| Interest paid | |||
| Interest received | |||
| Tax refunds | |||
| Taxes paid | |||
| Transaction costs related to debt refinancing | |||
| Net cash (outflow)/inflow from operating activities | |||
| Acquisition of assets, net of cash acquired | |||
| Acquisition of business | |||
| Purchase of property, plant and equipment | |||
| Purchase of investments | |||
| Maturity of investments | |||
| Purchase of intangible asset | |||
| Proceeds from disposal of intangible assets | |||
| Net cash outflow from investing activities | |||
| Proceeds from borrowings | |||
| Repayment of borrowings | |||
| Principal elements of lease payments | |||
| Lease incentive received | |||
| Shares repurchased and canceled | |||
| Proceeds from the issuance of ordinary shares | |||
| Net cash outflow from financing activities | |||
| Exchange difference on cash and cash equivalents | |||
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | |||
| Cash and cash equivalents at end of the period | |||
| Cash flows from operating activities: | |||
| Net income (loss) | |||
| Adjustments to reconcile net income to net cash from operating activities: | |||
| Depreciation and amortization | |||
| Amortization of right-of-use assets | |||
| Stock-based compensation expense | |||
| Impairment of tangible and intangible assets | |||
| Unrealized loss on equity investments | |||
| Deferred income taxes | |||
| Acquired in-process research and development | |||
| Impact from foreign exchange movements | |||
| Other adjustments, net | |||
| Change in operating assets and liabilities: | |||
| Accounts receivable | |||
| Current inventories | |||
| Other current and noncurrent assets | |||
| Accrued legal and settlement expenses | |||
| Other current and noncurrent liabilities | |||
| Net cash (used in) provided by operating activities | |||
| Cash flows from investing activities: | |||
| Purchases of property and equipment | |||
| Purchases of in-process research and development and intangible assets | |||
| Acquisitions, net of cash acquired | |||
| Purchases of investments in debt securities | |||
| Sales of equity securities | |||
| Sales and maturities of debt securities | |||
| Other proceeds from investing activities | |||
| Net cash (used in) provided by investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from the issuance of common stock | |||
| Cash paid for repurchases of common stock | |||
| Proceeds from debt, net | |||
| Repayments of debt | |||
| Transaction costs related to debt refinancing | |||
| Settlement of tax on equity awards | |||
| Net cash used in financing activities | |||
| Net (decrease) increase in cash and cash equivalents | |||
| Exchange differences | |||
| Cash and cash equivalents at beginning of period | |||
| Cash and cash equivalents at end of period |
Loading...